These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20336692)

  • 1. Proteus in the world of proteins: conformational changes in protein kinases.
    Rabiller M; Getlik M; Klüter S; Richters A; Tückmantel S; Simard JR; Rauh D
    Arch Pharm (Weinheim); 2010 Apr; 343(4):193-206. PubMed ID: 20336692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase inhibitors: insights into drug design from structure.
    Noble ME; Endicott JA; Johnson LN
    Science; 2004 Mar; 303(5665):1800-5. PubMed ID: 15031492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR backbone assignment of a protein kinase catalytic domain by a combination of several approaches: application to the catalytic subunit of cAMP-dependent protein kinase.
    Langer T; Vogtherr M; Elshorst B; Betz M; Schieborr U; Saxena K; Schwalbe H
    Chembiochem; 2004 Nov; 5(11):1508-16. PubMed ID: 15481030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha.
    Simard JR; Grütter C; Pawar V; Aust B; Wolf A; Rabiller M; Wulfert S; Robubi A; Klüter S; Ottmann C; Rauh D
    J Am Chem Soc; 2009 Dec; 131(51):18478-88. PubMed ID: 19950957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the NMR-based identification and optimization of allosteric protein kinase inhibitors.
    Jahnke W; Blommers MJ; Fernández C; Zwingelstein C; Amstutz R
    Chembiochem; 2005 Sep; 6(9):1607-10. PubMed ID: 16028302
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorophore labeling of the glycine-rich loop as a method of identifying inhibitors that bind to active and inactive kinase conformations.
    Simard JR; Getlik M; Grütter C; Schneider R; Wulfert S; Rauh D
    J Am Chem Soc; 2010 Mar; 132(12):4152-60. PubMed ID: 20201574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
    Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
    J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical approaches towards unravelling kinase-mediated signalling pathways.
    Hodgson DR; Schröder M
    Chem Soc Rev; 2011 Mar; 40(3):1211-23. PubMed ID: 21152652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplant-insert-constrain-relax-assemble (TICRA): protein-ligand complex structure modeling and application to kinases.
    Meshkat S; Klon AE; Zou J; Wiseman JS; Konteatis Z
    J Chem Inf Model; 2011 Jan; 51(1):52-60. PubMed ID: 21117680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-protein interactions in the allosteric regulation of protein kinases.
    Pellicena P; Kuriyan J
    Curr Opin Struct Biol; 2006 Dec; 16(6):702-9. PubMed ID: 17079130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel protein kinases and molecular mechanisms of autoinhibition.
    Cheetham GM
    Curr Opin Struct Biol; 2004 Dec; 14(6):700-5. PubMed ID: 15582394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacophore map of small molecule protein kinase inhibitors.
    McGregor MJ
    J Chem Inf Model; 2007; 47(6):2374-82. PubMed ID: 17941626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Displacement assay for the detection of stabilizers of inactive kinase conformations.
    Klüter S; Grütter C; Naqvi T; Rabiller M; Simard JR; Pawar V; Getlik M; Rauh D
    J Med Chem; 2010 Jan; 53(1):357-67. PubMed ID: 19928858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation.
    Romaker D; Schregel V; Maurer K; Auerochs S; Marzi A; Sticht H; Marschall M
    J Med Chem; 2006 Nov; 49(24):7044-53. PubMed ID: 17125257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery and the human kinome: recent trends.
    Eglen R; Reisine T
    Pharmacol Ther; 2011 May; 130(2):144-56. PubMed ID: 21256157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural modes of stabilization of permissive phosphorylation sites in protein kinases: distinct strategies in Ser/Thr and Tyr kinases.
    Krupa A; Preethi G; Srinivasan N
    J Mol Biol; 2004 Jun; 339(5):1025-39. PubMed ID: 15178245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docking interactions in protein kinase and phosphatase networks.
    Reményi A; Good MC; Lim WA
    Curr Opin Struct Biol; 2006 Dec; 16(6):676-85. PubMed ID: 17079133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doing more than just the structure-structural genomics in kinase drug discovery.
    Marsden BD; Knapp S
    Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophosphorylation kinetics of protein kinases.
    Wang ZX; Wu JW
    Biochem J; 2002 Dec; 368(Pt 3):947-52. PubMed ID: 12190618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.